Department of Medicine Archive — Page 12 of 79
-
March 28, 2023
Inflammation implicated in exfoliation syndrome
Computational genetics tools have implicated inflammatory pathways in exfoliation syndrome, the most common cause of secondary glaucoma, which can result in blindness. -
March 23, 2023
VUMC accredited for primary ciliary dyskinesia care
Vanderbilt University Medical Center has been named a fully accredited adult PCD (primary ciliary dyskinesia) Foundation Clinical and Research Center site. -
March 23, 2023
Saunders receives diabetes research innovation award
Vanderbilt's Diane Saunders, PhD, has been selected as a 2023 recipient of an Innovation Award by the Network of Pancreatic Donors with Diabetes. -
March 16, 2023
Study evaluates polygenic risk score for prostate cancer risk prediction
A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening. -
March 16, 2023
Eng stresses need for clinical trial support at cancer forum
Vanderbilt's Cathy Eng, MD, stressed the need for more patient participation and better funding for clinical trials to improve colorectal cancer treatment and outcomes during the White House Cancer Moonshot Colorectal Cancer Forum. -
March 9, 2023
Study finds RSV may evade vaccines via rapid mutation
A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading. -
March 6, 2023
Cell-free hemoglobin in pulmonary hypertension
Cell-free hemoglobin generated by the lungs may be a therapeutic target for treating pulmonary arterial hypertension, Vanderbilt researchers found.